4/A: Genelux Corp Director Corrects Stock Option Exercise Price in Amended SEC Filing
SEC Filing Amendment
A Genelux Corp director filed an amended SEC Form 4 to correct the exercise price of a stock option grant.
Summary
- A director of Genelux Corp, Mary Mirabelli, filed an amended Form 4 with the SEC.
- The amendment corrects a previous filing from August 5, 2024, which incorrectly stated the exercise price of a stock option.
- The correct exercise price for the stock option is $1.96 per share, not $1.54 as previously reported.
- The stock option was granted on August 1, 2024, and covers 50,469 shares of common stock.
- The options vest on the earlier of the one-year anniversary of the grant date or the date of the next annual meeting of stockholders.
- The options expire on July 31, 2034.
Sentiment
Score: 7
Explanation: The document is a routine correction of a previous filing. While the initial error is a minor negative, the prompt correction is a positive. Overall, the sentiment is neutral to slightly positive.
Negatives
- The original filing contained an error regarding the stock option exercise price.
Risks
- Scrivener's errors in SEC filings can lead to confusion and potential compliance issues.
Industry Context
This filing is a routine disclosure related to insider transactions and is common for publicly traded companies. The correction of the exercise price is a standard procedure to ensure accuracy in SEC filings.
Comparison to Industry Standards
- The filing of Form 4s for insider transactions is a standard practice for all publicly listed companies in the US.
- The correction of errors in SEC filings is also a common occurrence, and the company has taken the appropriate steps to rectify the mistake.
- The vesting schedule of the options is typical, with vesting tied to either a time-based milestone or a corporate event.
Stakeholder Impact
- The correction ensures transparency for shareholders regarding insider transactions.
- The correction has a minor impact on stakeholders as it clarifies the terms of the stock option.
Key Dates
| Date | Description |
|---|---|
| 08/01/2024 | Date of the stock option grant. |
| 08/05/2024 | Date of the original Form 4 filing with the incorrect exercise price. |
| 12/31/2024 | Date of the signature on the amended filing. |
| 07/31/2034 | Expiration date of the stock options. |
Keywords
SEC Filing, Form 4, Stock Option, Genelux Corp, Director, Amendment, Beneficial Ownership, GNLX
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.